Researchers have identified a protein called MTCH2, or “Mitch,” that regulates how human cells process fat and energy, potentially offering a new target for future obesity treatments. According to a 2025 study published in the EMBO Journal, disabling this protein in human cells forces them to burn more fuel and inhibits the formation of new … Read more
Immune aging, or immunosenescence, triggers a decline in the body’s ability to fight infections and tumors while simultaneously increasing the risk of chronic inflammation and autoimmune diseases. According to a review published in the Journal of Clinical Investigation, the human immune system reaches a critical inflection point around age 50, where molecular signatures of aging … Read more
Researchers at the MUSC Hollings Cancer Center have identified a mechanism that allows prostate cancer cells to survive treatment by hijacking a protein called PIM1. According to a study published in Cancer Letters, traditional therapies that block PIM1 signaling inadvertently trigger a survival response, prompting the team to develop a “degrader” compound known as PIMTAC … Read more
Researchers at ETH Zurich have identified a new chemical compound, dubbed “Compound 10,” that shows potential in slowing the progression of Alzheimer’s disease by targeting the enzyme GRK2. According to findings published in Cell Reports Medicine, the substance prevents the formation of harmful enzyme aggregates in brain cells, offering a distinct mechanism compared to existing … Read more
The Hidden Chemistry of Aging: Why Our Mitochondrial “Power Grid” Fades We often think of aging as a gradual loss of vitality, but at the cellular level, the process is surprisingly specific. For years, scientists have focused on the “powerhouses” of our cells—the mitochondria—and their inevitable decline. However, a groundbreaking study published in Nature Communications … Read more
Beyond Chemotherapy: The Rise of Bacteria-Inspired Oncology For decades, the war on cancer has been fought with “sledgehammer” approaches—chemotherapy and radiation designed to kill rapidly dividing cells. While effective, these methods often leave healthy tissue in the crossfire. However, a paradigm shift is occurring in oncology. Instead of just attacking the cell, scientists are now … Read more
Starving the Tumor: The Rise of Bacterial-Inspired Cancer Therapies For decades, the war on cancer has largely focused on attacking the cell’s ability to divide. But, a paradigm shift is occurring. Researchers are now looking at how to “starve” cancer by targeting its energy source: the mitochondria. View this post on Instagram about Starving the … Read more
The New Frontier of Precision Oncology: Targeting DNA Repair Pathways For years, the medical community has viewed BRCA1 and BRCA2 mutations as significant risk factors for breast, ovarian and other cancers. These mutations strip cells of their primary tumor-suppression functions, leaving them vulnerable. However, cancer cells are notoriously adaptable. They often find “workarounds” to survive … Read more
Parkinson’s Disease: A New Target in Fat Metabolism? A newly identified enzyme, glycerol-3-phosphate acyltransferase (GPAT), is emerging as a potential key player in the progression of Parkinson’s disease. Research from Nanyang Technological University, Singapore (NTU Singapore) suggests that GPAT’s role in fat production within brain cells could amplify the damage caused by the protein α-synuclein, … Read more
Red Blood Cells: The Unexpected Key to Glucose Control and Altitude Adaptation For decades, red blood cells (RBCs) were considered primarily oxygen carriers, simple transport vehicles lacking significant metabolic regulation. However, recent research is dramatically reshaping this understanding, revealing RBCs as active players in glucose metabolism, particularly in response to low oxygen conditions like those … Read more